Sanofi's SAR444881 tumor trial results posted after early stop; hemophilia study recruitsSep 29Weekly roundup, 2 itemsSanofi
Lilly registers three new early trials: olomorasib in colorectal cancer, two obesity studiesSep 11Weekly roundup, 3 itemsEli Lillyeloralintide
Pyxis Oncology reports updated Phase 1 data for MICVO in head and neck cancerSep 9Clinical readoutPyxis Oncology, Inc
BridgeBio Oncology reports Q2 2026 results, starts two KRAS inhibitor combination trialsAug 11Quarterly updateBridgeBio Oncology Therapeutics, Inc.
Adlai Nortye clears Australian regulatory steps for AN4035 phase I trialAug 3Regulatory decisionAdlai Nortye Group Ltd.
Ascentage Pharma names new Chief Business Officer and Chief Commercial OfficerAug 3PeopleAscentage Pharma Group International
Results post for old USC gastric cancer trial; Bristol Myers Squibb opens new Zeposia PML studyJul 30Weekly roundup, 3 itemsBristol Myers Squibbiberdomide
Lilly posts SURPASS-CVOT results; tirzepatide compared to dulaglutide on cardiovascular eventsJul 10Weekly roundup, 8 itemsAstraZenecabaricitinib
Sign inSign in